Penumbra Inc (NYSE:PEN)

195.52
Delayed Data
As of Oct 03
 +5.92 / +3.12%
Today’s Change
114.87
Today|||52-Week Range
290.36
-31.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.2B

Company Description

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. Its target markets include interventional neuroradiologists, neurosurgeons, neurologists, cardiologists, radiologists, and vascular surgeons. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

Contact Information

Penumbra, Inc.
One Penumbra Place
Alameda California 94502
P:(510) 748-3200
Investor Relations:
(510) 748-3259

Employees

Shareholders

Mutual fund holders60.95%
Other institutional22.15%
Individual stakeholders10.69%

Top Executives

Adam ElsesserChairman, President & Chief Executive Officer
Ben SorciExecutive Vice President-Operations
Maggie S. YuenChief Financial Officer
Pankaj TiwariChief Information Officer & Executive VP
Michaella CorsoVice President-Clinical Affairs